Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search for:

Search

Recent Posts

IsomAb Announces Strategic Collaboration with Catalent
IsomAb Announces Nomination of Development Candidate for Peripheral Arterial Disease and Strategic Collaboration with Pfizer
IsomAb Announces the Expansion of its Clinical Advisory Board
IsomAb Appoints Dr Anker Lundemose as a Non-Executive Director
IsomAb Announces Close of £7.5 Million Financing to Accelerate Lead Candidate for Treatment of Peripheral Arterial Disease